Cite
MLA Citation
Jonathan Barratt et al.. “MO533: Safety of Roxadustat versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients With Chronic Kidney Disease Incident to or not Receiving Dialysis: Pooled Analysis of Four Phase 3 Studies.” Nephrology dialysis transplantation, vol. 37, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100158000696.0x000046